Nimotuzumab Plus Paclitaxel and Cisplatin as a 1
<sup>st</sup>
-Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II Study

Nimotuzumab Plus Paclitaxel and Cisplatin as a 1 ^st -Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II Study

Zhang, Xiaodong; Jia, Jun; Lu, Ming; Wang, Xicheng; Gong, Jifang; Li, Jie; Li, Jian; Li, Yan; Zhang, Xiaotian; Lu, Zhihao; Zhou, Jun; Yu, Jing; Sun, Zhiwei; Yang, Ying; Liu, Chuanling; Xiao, Yanjie; Shen, Lin

期刊名称Journal of Cancer
作者Zhang, Xiaodong; Jia, Jun; Lu, Ming; Wang, Xicheng; Gong, Jifang; Li, Jie; Li, Jian; Li, Yan; Zhang, Xiaotian; Lu, Zhihao; Zhou, Jun; Yu, Jing; Sun, Zhiwei; Yang, Ying; Liu, Chuanling; Xiao, Yanjie; Shen, Lin
卷第10卷
期第6期
印刷ISSN1837-9664
文件大小428.93KB
发表时间2019
DOI10.7150/jca.28659
页码1409-1416

发现好书期刊，享受阅读乐趣

Nimotuzumab Plus Paclitaxel and Cisplatin as a 1 st -Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II Study

Nimotuzumab Plus Paclitaxel and Cisplatin as a 1 ^st -Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II Study